6 projets européens trouvés
Recherche sur 125080 projets européens
TERMINÉ
Advanced solutions for assuring the overall authenticity and quality of olive oil (OLEUM)
Date du début: 1 sept. 2016, Date de fin: 31 août 2020,
The OLEUM project will generate innovative, more effective and harmonized analytical solutions to detect and fight the most common and emerging frauds and to verify the overall quality of olive oils (OOs). By a core group of 20 partners from 15 countries OLEUM will undertake RESEARCH ACTIVITIES based on the development of IMPROVED and NEW ANALYTICAL METHODS by targeted and omics approaches with th ...
Voir le projet
24
Participants partenaires
TERMINÉ
A training network for the rational design of the next generation of well-defined glycoconjugate vaccines (GLYCOVAX)
Date du début: 1 nov. 2015, Date de fin: 31 oct. 2019,
GLYCOVAX is a network for the education of promising young scientists who will learn how to rationally design a next generation of well-defined and innovative glycoconjugate vaccines to improve current preventive therapies and to tackle unmet medical needs. Glycoconjugate vaccines represent the key for success of vaccination in children. The covalent linkage to proteins renders carbohydrates able ...
Voir le projet
12
Participants partenaires
TERMINÉ
Strengthening adaptive immunity via innate immunity: enhancing the CD8 T cell response by using the NKG2D ligand expressed in a herpesvirus vector (StAdvInn)
Date du début: 1 mai 2013, Date de fin: 30 avr. 2018,
CD8+ T cells play a key role in the control of infections by intracellular pathogens. Recently, several top-notch studies provided ample evidence that NK cells are important in the regulation of CD8+ T cell response. NKG2D is an activating NK cell receptor which plays a role in the adaptive immune response by co-stimulating CD8+ T cells. Due to unique pattern of immune response, live attenuated CM ...
Voir le projet
2
Participants partenaires
TERMINÉ
Methods for high-throughput glycoproteomic analysis (HTP-GlycoMet)
Date du début: 1 nov. 2013, Date de fin: 31 oct. 2017,
The main aim of the HTP-GlycoMet proposal is to develop technologies, which will enable high-throughput analysis of glycosylation of individual proteins from body fluids and cell membranes and apply them to understand some key processes in immunity and infections. Glycan analysis is extremely demanding from both technological and conceptual aspect and (beside one study performed by partners in thi ...
Voir le projet
6
Participants partenaires
TERMINÉ
DRIVING RE-INVESTMENT IN R&D AND RESPONSIBLE ANTIBIOTIC USE (DRIVE-AB)
Date du début: 1 oct. 2014, Date de fin: 30 sept. 2017,
Antimicrobial resistance (AMR) is widespread. Its global human and economic burden is tremendous and increasing annually. Yet today only a few pharmaceutical companies retain active antibacterial drug discovery programmes. While the elaboration of antibiotics with novel mechanisms of action is scientifically complex, the chief challenge is diminishing incentives. Pre-market regulatory requirements ...
Voir le projet
27
Participants partenaires
TERMINÉ
Memory Control; The role of NKG2D and the T-cell receptor in memory T cell biology (NKG2D in T-cells)
Date du début: 1 juin 2011, Date de fin: 31 mai 2013,
Despite our advances in medical sciences, infectious diseases such as HIV and Hepatitis C remain an important health problem for our society. Also, targeting the immune system towards cancer is a promising therapy to fight this disease. Cellular immunity mediated by memory CD8 T-cells provides vital protection against infections and the development of tumors. Understanding the formation and mainte ...
Voir le projet